For three days this week, Doha's medical-technology market came together in one hall. QMED 2026, the third Qatar International Medical Devices & Healthcare Exhibition & Conference, ran from 14 to 16 October at the Qatar National Convention Centre under the patronage of the Ministry of Public Health (Qatar Tribune). Qatar Development Bank (QDB) joined as Strategic Development Partner and hosted a pavilion of Qatari manufacturers and healthcare companies (Qatar Tribune). Now that the stands are packed away, healthtech founders and SME suppliers face a practical question: where is the real demand, and what is the route to it?

The strategy behind the spending

The anchor document is the National Health Strategy 2024–2030, launched in September 2024. It sets three priorities: better population health and well-being, a more efficient and resilient health system, and excellent service and patient experience. These are delivered through 15 outcomes over seven years (Marhaba). Three commitments in it matter most for innovators:

  • Digitise the health system, with data-driven decision-making and investment in applied health intelligence.
  • Expand public-private partnerships as part of the efficiency and resilience priority.
  • Increase research and development and invest in biotechnology and medical security.

The outcome targets are ambitious. They include raising life expectancy to 82.6 years, cutting deaths from non-communicable diseases by 36% and reducing infant mortality to two per 1,000 live births.

Where the money is

Oxford Business Group's 2026 review of the sector gives a sense of scale (OBG):

  • QR25.4bn is allocated to health in the 2026 general budget, up from QR22bn in 2025.
  • Government health spending is projected to reach around US$12.8bn–12.9bn by 2029. That is a projection, not a budget line.
  • Twelve major PPP hospitals are operational or under construction under Law No. 12 of 2020, expected to add 1,200 beds.
  • The digital health market is estimated at around US$580m, following roughly US$1.5bn of digital-health investment under the previous national strategy.

Telehealth is also becoming normal. The Primary Health Care Corporation runs the Nar'aakom teleconsultation platform. In its own survey, 83% of patients found virtual consultations easy to use and 80% felt their concerns were addressed remotely (OBG).

Four places healthtech fits

Reading the strategy alongside the spending, four openings stand out. This is our analysis, not an official list:

  • Chronic-disease management. The 36% NCD mortality target needs tools for remote monitoring, adherence and population-health analytics. OBG cites a US$1.7m research grant to Lillia for an AI platform that manages chronic diseases as an example of public backing (OBG).
  • Selling into PPP hospitals. New privately operated facilities need equipment, software, maintenance and services. QDB's stated aim for QMED was to strengthen healthcare supply-chain sustainability and build national capabilities, which points local suppliers toward these buyers.
  • Virtual care and patient experience. "Excellent service and patient experience" is one of the three national priorities, and patients already accept teleconsultation.
  • Health financing and payments. Health insurance is compulsory for expatriate workers and visitors (OBG), which creates claims and billing workflows. Medica Technologies, a Qatari platform for healthcare financing and payments, is in QBIC's 2026 accelerator cohort (Arab Founders).

Routes in: pilots, programmes and partners

In healthcare, a clinical pilot is often worth more than a funding round, because buyers want evidence. Several routes are open:

  • QBIC's accelerator. The 2026 cohort of 20 startups spans AI, logistics, healthtech and sustainability. It offers mentorship, workspace, links to funding networks and potential pilots with national institutions (Arab Founders).
  • Sidra Medicine and Rasmal Ventures. Under a 2025 memorandum, Rasmal introduces e-health startups to Sidra, and Sidra uses its clinical and research expertise to test them. Priority areas are patient-centric AI, telemedicine and wearables. Sidra's Chief Research Officer described the aim as turning Sidra into "a living lab for entrepreneurial ventures" (Rasmal Ventures).
  • QSTP x Merck FemTech Accelerator. This programme for women's-health ventures charges no fee, takes no equity, and supports pilot design with providers and regulators. The 2026 cohort is under way, with a Doha showcase planned for November (QSTP). Founders should watch for the next intake.

The barriers to plan for

  • Clinical talent and licensing. Licensing and accreditation of practitioners through the Qatar Council for Healthcare Practitioners averages 75 days, and around 90% of medical staff are expatriates (OBG). If your model depends on licensed clinicians, build that lead time into your plan.
  • Health data is special-category data. Under Qatar's Personal Data Privacy Protection Law, health data is "personal data of a special nature". Regulatory guidance requires authorisation before processing it and makes a data protection impact assessment mandatory for new processing (Clyde & Co). Check the current requirements with the regulator before launch.
  • Trust. About 70% of healthcare providers expressed concern about data breaches, according to a 2025 study cited by OBG. Expect hospital buyers to examine security and hosting before they look at features.

Connecting to Vision 2030 and NDS3

A healthy population is central to the human development goals of Qatar National Vision 2030. The Ministry of Public Health linked its QMED patronage to working with the private sector in line with the Third National Development Strategy, and QDB said its partnership supports NDS3's aim of expanding the private sector's role in healthcare (Qatar Tribune). For founders, that means policy is pointing toward private-sector solutions. The work is to prove clinical and economic value.

What to do next

  • Map your product to one of the 15 National Health Strategy outcomes, and use that language in every pitch to a public buyer.
  • Choose a pilot route (QBIC, Sidra's living-lab model or a QSTP programme) and define in advance the clinical and cost metrics a successful pilot must show.
  • Get your health-data authorisation, impact assessment and hosting plan in order before your first hospital conversation.
  • Follow up QMED contacts now, especially PPP hospital operators and QDB pavilion companies that could become channel partners.

Sources

Photo: Marta Branco / Pexels

0 تعليق

أحدث القصص

لا يتضمن هذا القسم حاليًا أي محتوى. أضف محتوى إلى هذا القسم باستخدام الشريط الجانبي.
© 2026 Falak. مدعوم من شوبيفاي